NCT00418834View on ClinicalTrials.gov

Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,053

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Hypercholesterolemia

Interventions

DRUG

ezetimibe and atorvastatin

ezetimibe 10 mg and atorvastatin 10 mg daily for 12 weeks

DRUG

atorvastatin

Atorvastatin 20 mg daily for 6 weeks, and up-titrated to atorvastatin 40 mg daily for an additional 6 weeks

DRUG

Placebo (unspecified)

Placebo (unspecified) daily for 12 weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00418834 - Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112) | Biotech Hunter | Biotech Hunter